Phase II study of chemoradiotherapy for advanced squamous cell carcinoma of the thoracic esophagus: Nine Japanese institutions trial

Japanese Journal of Clinical Oncology

Volumn 26, Issue 5, 1996, Pages 310-315

  Ishida, Kaoru ^a   Iizuka, Toshifumi ^b   Ando, Nobutoshi ^c   Ide, Hiroko ^d  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b National Oji Hospital   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Chemoradiotherapy; Esophageal carcinoma; Phase II study

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; CISPLATIN; FLUOROURACIL;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CLINICAL TRIAL; ESOPHAGUS TUMOR; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; PHASE 2 CLINICAL TRIAL; QUALITY OF LIFE; RECURRENT DISEASE; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; RADIOTHERAPY, ADJUVANT; RECURRENCE;

EID: 0030266595     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jjco.a023238     Document Type: Article

References (16)

1. Japanese Committee for Registration of Esophageal Carcinoma Cases: Parameterers linked to ten-year survival in Japan of resected esophageal carcinoma. Chest 96: 1005-1011, 1989
2. Lerut TE, de Leyn P, Coosemans W, Van Raemdonck D, Cuypers P, Van Cleynenbreughel B: Advanced esophageal carcinoma. World J Surg 18: 379-387, 1994
3. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5: 649-655, 1982
4. International Union Against Cancer. TNM Classification of Malignant Tumours, 4th ed, Springer-Verlag, Berlin. 1987
5. Japanese Society of Esophageal Diseases: Gidelines for Clinical and Pathologic Studies on Carcinoma of the Esophagus, 6th ed, Kanehara Co. Ltd., Tokyo. p24, 1984
6. Japan Society for Cancer Therapy: Criteria evaluating the results of chemotherapy for Cancer. Nippon Gan Chiryo Gakkai Shi 21: 929-942, 1986 (in Japanese)
7. Welch HG, Larson EB: Cost effectiveness of bone marrow transplantation in acute nonlymphocytic leukemia. N Engl J Med 321: 807-812, 1989
8. Siewert JR, Roder JD: Lymphadenectomy in esophageal cancer surgery. Dis Esophagus 5: 91, 1992
9. Ide H, Nakamura T, Hayashi K, Endo T, Kobayashi A, Eguchi R, Hanyu F: Esophageal squamous cell carcinoma: pathology and prognosis. World J Surg 18: 321-330, 1994
10. Iizuka T, Kakegawa T, Ide H, Ando N, Watanabe H, Tanaka O, Takagi I, Isono K, Ishida K, Arimori M, Endo M, Fukushima M: Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japanese Esophageal Oncology Group Trial. Jpn J Clin Oncol 22 :172-176, 1992
11. Kelsen D: Carcinoma of the Esophagus. ASCO Educational Booklet 1990, 51-71, 1990
12. Leichman L, Herskovic A, Leichman CG, Lattin PB, Steiger Z, Tapazoglou E, Rosenberg JC, Arubulu A, Asfaw I, Kinzie J: Nonoperative therapy for squamous-cell cancer of the esophagus. J Clin Oncol 5: 365-370, 1987
13. Kolaric K, Zeljko M, Anton R, Ivo D: Combination of bleomycin and adriamycin with or without radiation in the treatment of inoperable esophageal cancer. Cancer 45: 2265-2273, 1985
14. Coia L, Engstrom P, Paul A: Nonsurgical management of esophageal cancer: report of study of combined radiotherapy and chemotherapy. J Clin Oncol 5: 1783-1790, 1987
15. Keane TJ, Harwood AR, Elhakim T, Rider WD, Cummings BJ, Ginsberg RJ, Cooper JC: Radical radiation therapy with 5-fluorouracil infusion and mitomycin C for oesophageal squamous carcinoma. Radiother Oncol 4: 205-210, 1985
16. John M, Flam M, Wittlinger P, Mowry PA: Inoperable esophageal carcinoma: results of aggressive synchronous radiotherapy and chemotherapy: a pilot study. Am J Clin Oncol 10: 310-316, 1987